PGY-2 Investigational Drugs and Research Pharmacy Residency

Contact Information: 
UC Davis Health
Pharmacy Department
2315 Stockton Blvd, Room 1310
Sacramento, CA 95817

Residency Program Director

Jennifer Murphy, PharmD, BCOP
Senior Pharmacist, Oncology & Investigational Drug Service
Investigational Drug Service, Cancer Center (IDSCC)
Assistant Clinical Professor, UC San Francisco School of Pharmacy

2022-2023 Resident:
Kim Chi Nguyen, PharmD

Residency Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.Residents who successfully complete the PGY2 Investigational Drugs and Research Pharmacy Residency are prepared to step into an advanced pharmacist a roll within an IDS or pharmaceutical company with the skillset to provide specialized care to clinical trials patients, manage the regulatory requirements associated with clinical trials, design and contribute to trial design and oversee related operations to conduct clinical research. Graduates of the program will have developed competency to provide safe, high quality, multidisciplinary, specialty care to patients enrolled in clinical trials. Additionally, the aim is for residents of this program to develop clinical, analytical, teaching, and leadership skills to support clinical trials research in a positive learning environment that promotes independent, critical thinking, creativity, and a culture of mutual respect.

Program Overview

PGY-2 Investigational Drugs and Research Pharmacy Residency team
Investigational Drug Service team members

The Investigational Drugs and Research Pharmacy Specialty Residency at the University of California, Davis Medical Center, is a one-year, PGY2 specialty residency in Investigational Drug Services and Research Pharmacy Practice. The residency is supported by the Department of Pharmacy. The Investigational Drug Services (IDS) is a strong, well-established, and progressive center of excellence at the UC Davis Medical Center. The IDS manages investigational drugs for a robust portfolio of Phase I, II, and III studies which are conducted through the UC Davis Medical Center hospital, hospital-based clinics, Alpha Stem Cell Clinic, and UC Davis Cancer Center. The UC Davis Cancer Center is a Comprehensive Cancer Center, as designated by the National Cancer Institute as well as a member of the National Comprehensive Cancer Network and the Alpha Stem Cell Clinic is a CIRM award recipient. UCMDC is home to the Sacramento Citywide Oncology Phase I Program (SCOPE) and within the top recipients for NIH funding with individual researchers within the top percentage of recipients. At UC Davis Medical Center, IDS agents are dispensed from various pharmacy locations including the main IDS pharmacy, IDS Cancer Center Pharmacy, central IV pharmacy, Inpatient Oncology Pharmacy, outpatient pharmacies, and the UC Davis Cancer Center Infusion Pharmacy. The Investigational Drugs and Research Pharmacy Specialty Residency will provide each resident with a comprehensive training and educational experience in clinical trial pharmacy practices.

UC Davis Medical Center and Pharmacy Services

UC Davis Medical Center is a major academic health center located in Sacramento, California. Pharmacy services recruits, hires, and trains caregivers to provide progressive pharmacy services as collaborative team members to support optimal patient outcomes.
More about the Department can be found on our Webpage

Program Design

The UC Davis Medical Center PGY2 Investigational Drugs and Research Residency is designed to meet the educational goals and objectives, as outlined by the ASHP PGY2 IDR Residency Accreditation Standard.

Educational Outcomes Required by the Accreditation Standard:

R1. Patient Care
R2. Advancing Practice and Improving Patient Care
R3. Research Protocols and Regulations
R4. Leadership and Management
R5. Teaching, Education, and Dissemination of Knowledge
Electives may be added based on available resources and resident interest

Program Structure

The PGY2 Investigational Drugs and Research Residency is a full-time, one-year commitment, beginning on July 1 and ending on June 30, unless alternative dates are pre-arranged. Clearance to start work by UC Davis Medical Center Employee Health and a Human Resources orientation meeting must be completed prior to August 1.

Proposed Calendar of Activities:

Quarter 1

Quarter 2

Quarter 3

Quarter 4


  • Orientation/training
  • Intake assessment
  • Establish residency goals/individualized development plan
  • Selection of research and Grand Rounds project topics
  • 1st committee rotation


  • Rotation Block
  • Pharmacy Research Summit
  • Conduct/ finalize research project
  • Pharmacy week
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan
  • 2nd committee rotation


  • Rotation Block
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan
  • 3rd committee rotation


  • Rotation Block
  • Quarterly self and RPD assessments of longitudinal learning experiences and development plan
  • HOPA Annual Conference
  • 4th committee rotation


  • Rotation Block
  • Preparation of research protocol
  • IRB submission
  • Fall resident retreat
  • 1st committee rotation


  • Rotation block
  • 2nd committee rotation


  • Rotation block
  • Compile research project results
  • Prepare draft presentation to RPD & preceptors
  • PGY2 interviews
  • 3rd committee rotation


  • Rotation block
  • UC Collaborative residency conference
  • Spring resident retreat
  • 4th


  • Rotation Block
  • Identification of monograph or QI project
  • 1st committee rotation


  • Rotation Block
  • ASHP Midyear Clinical Meeting (optional)
  • Quarterly development plan
  • Prepare abstract for submission to HOPA
  • Review residency candidate packets
  • Holiday/PTO
  • Project time
  • 2nd committee rotation


  • Rotation Block
  • Research project deliverables
  • 3rd committee rotation


  • Rotation Block
  • 4th committee rotation
  • Manuscript submission
  • End of residency closeout and program improvement evaluation
  • Residency Requirements

Longitudinal Activities

  • Residency research project
  • Case conference/Lecture series
  • Committee assignments
  • Teaching Program (if not completed during PGY1)
  • Teaching Opportunities (integrated into rotations)
  • Mentorship program
  • Dept of Pharmacy Service requirements including evening staffing (3 separated weeks)

UC Davis Medical Center PGY2 Investigational Drugs and Research Residency Learning Experiences:

The residency learning experiences will primarily be divided into block rotations and longitudinal learning experiences. The majority of rotations will be 4 weeks in duration. Rotation schedules will be determined based on availability and resident interests and will be designed to include all required CAGOs as well as a variety of clinical experiences and environments. Rotation schedules will be adjusted and updated quarterly, in conjunction with preparing the updated development plan.

  • Rotations can be extended or repeated per the resident’s interests
  • Each longitudinal experience will have some concentrated block time
  • Project time will be coordinated throughout the year as arranged with the PGY-2 Investigational Drugs and Research RPD

Required Learning Experiences

Type of Experience

Orientation/training Block
(4 weeks)
Orientation to UC Davis Medical Center and the residency program. Duration may be adjusted based on the resident’s previous experience and knowledge of UC Davis Medical Center. Training for weekend IDS and evening service coverage will occur during this time.
Research and Scholarship Longitudinal
(12 months)
Identification and completion of a research project in the area of clinical interest or departmental need as agreed upon the resident and RPD. Attention to the deliverables set forth by the Pharmacy Research Oversight Committee facilitates successful completion of the project.
Grand Rounds Longitudinal
(12 months)
The resident will work with the RPD on a selected topic and prepare an ACPE accredited pharmacy grand rounds presentation. A presentation, to an external department or entity, that is deemed to be equivalent may be permitted as an alternative.
Ambulatory Care (non-Oncology) Clinic Block
(4 weeks)
Ambulatory clinic rotation in setting with robust clinical trial enrollment. Clinic experience(s) will be assigned based on current clinical trial portfolio to provide exposure to patient populations, clinic workflow, recruitment, retention, and treatment workflows, study team member roles, and clinical trials treatment. Clinic options may include, but are not limited to: Infectious Disease, Pulmonary Critical Care, Physical Medicine & Rehab, Neurology, or Transplant (clinic site selection subject to current IDS trial portfolio).
Investigational Drug Service I Block
(4 weeks)
Provides introduction to processes related to dispensing and managing investigational drugs and clinical trials in the non-oncology IDS Pharmacy.
Investigational Drug Service Cancer Center I Block
(4 weeks)
Provides introduction to processes related to dispensing and managing investigational drugs and clinical trials in the IDS Cancer Center Pharmacy.
(3 weeks)
The BEACON LE offers the resident focused time working with the BEACON IDS pharmacist and interactions with the BEACON EMR and IDS ERX team to develop new BEACON regimens, new ERX, reviewing content for accuracy, providing documentation for content development from investigational protocol and validation of the regimen prior to implementation.
Stem Cell Transplant Service or Inpatient Medical Oncology Block
(4 weeks)

Clinical rotation with the inpatient medical oncology service. Focus will be on patients treated with clinical trial regimens.

Clinical rotation the stem cell transplant team. Includes inpatient service and weekly SCT clinic. Focus will be on patients treated with clinical trial regimens.

Institutional Review Board (IRB) / Regulatory Affairs Block
(4 weeks)
LE provides exposure to topics of informed consent, ethics of human subject research, FDA inspections, the IRB role and responsibilities as well as attendance at the IRB with IRB an IRB pharmacist committee member.
Pediatric Oncology Block
(4 weeks)
Clinical rotation with the pediatric oncology outpatient clinic and infusion pharmacy services. Outpatient Pediatric Oncology and hemophilia clinics.
Research Quality and Safety Block
(4 weeks) + Longitudinal
The concentrated Research Quality and Safety rotation will provide the resident with exposure to medication safety process, procedures, workflows, and the opportunity to develop process improvement skills.
Investigational Drug Services Pharmacy Practice Management Block
(4 weeks)
Concentrated learning experience that captures many of the global and regulatory objectives of the PGY2 Investigational Drug & Research Residency training program, including medication management, compliance with USP and BOP requirements for handling hazardous drugs, oversight of learners and clinical teaching responsibilities. Includes 4 weeks of concentrated learning with Oncology/ IDS Management Team.
Lung Cancer Clinic Concurrent with IDSCC rotation Lung cancer clinic provides focused learning in the management of patients with lung cancers. Includes 1 weekly clinic with a UCDMC lung cancer physician and participation in weekly Thoracic Tumor Board meeting.
Investigational Drug Service II or IDS Cancer Center II
(4 weeks)
The second IDS rotation will focus on the coordination of activities in the IDS Pharmacy. The emphasis will be focused on review and implementation of clinical trials and pharmacy workflow management.
Project Block Block
(5 days plus 5 floating days)
Dedicated time to work towards completion of longitudinal research project

Longitudinal Experiences

  • Protocol Development
  • Research Quality and Safety
  • IDS Pharmacy Practice Management
  • Research Project
  • Weekend IDS Service Coverage
  • DPS Evening Support
  • Research Compliance and Business Practice

Elective Experiences

  • Alpha Stem Cell Clinic
  • Cancer Center Infusion Center
  • Protocol Development

Assignment of Education Goals and Objectives to Specific Learning Experiences – see learning experiences and objectives outlined in PharmAcademic.

UC Davis Medical Center PGY2 Investigational Drugs and Research Resident’s Role in Teaching:
UC Davis Medical Center offers many opportunities for both clinical and didactic teaching. The resident will be responsible for assisting preceptors with clerkship teaching for University of California, San Francisco pharmacy students. As opportunities present, the resident will be engaged in teaching and precepting before assuming the primary preceptor role for UCSF pharmacy students in the latter part of the residency.

The resident will be required to prepare an ACPE accredited pharmacy grand rounds presentation or pharmacy competency presentation. In addition, the PGY2 Investigational Drugs and Research resident may choose to participate in academic teaching, as requested by regional schools of pharmacy, with the approval of the PGY2 Investigational Drugs and Research Residency Director.

Residency Research Project:
All UC Davis Medical Center PGY2 residents are required to complete a research project and present their research in a podium presentation at the UC Collaborative Conference or other regional meeting. In preparation for conducting their research project, the resident will complete UC Davis Medical Center IRB-required training and certification. The resident will prepare a project proposal, which will be reviewed and approved by the UC Davis Medical Center Pharmacy Residency Oversight Committee (PROC). The resident will also submit their project to the Pharmacy and Therapeutics Committee. They will submit the project to the IRB for review, before embarking on their research. Upon completion of the project, the resident will be required to summarize their research project for the Departmental newsletter and prepare a manuscript. PGY2 residents will submit their manuscripts for publication and prepare an electronic poster suitable for submission.

Committee Assignments:
The PGY2 Investigational Drugs and Research resident will participate in various committee activities, as assigned by the PGY2 Investigational Drugs and Research residency director. Assignments will be determined based on current department initiatives. The purpose of the resident’s committee involvement is to ensure the resident gains exposure to the pharmacist’s role in emerging therapies and investigational drug services.

Professional Development:
The PGY2 Investigational Drugs and Research resident is encouraged to maintain an active role in pharmacy professional organizations. The resident is strongly encouraged to attend the Pharmacy Research Summit as well as to become a member of the Hematology Oncology Pharmacists Association (HOPA) and attend their annual meeting in the early Spring. The resident will be provided with some financial support from the institution and professional leave time to facilitate participation in professional development activities.

Pharmacy Department Service:
The PGY2 Investigational Drugs and Research resident will be expected to provide approximately 400 hours of pharmacy department service. This expectation will be met primarily by providing Investigational Drug Service pharmacist coverage (approximately 280 hours; every third weekend) plus one major holiday (Thanksgiving; Christmas Eve; Christmas Day; New Year’s Eve; New Year’s Day) as well as providing 120 hours of evening Department of Pharmacy support.

Required Competencies:
Residents function as licensed pharmacists in patient care activities. As such, minimum knowledge in a variety of areas must be assured. Within one month of starting the Residency, the resident must complete competencies required of all clinical pharmacists, including Basic Life Support (BLS) and Advanced Cardiac Life Support (ACLS)

Resident Portfolio:
Each resident must maintain a portfolio containing all information from the residency year including but not limited to: copies of papers or projects done during rotations, lectures given, research project manuscript and secondary projects. The portfolio shall be maintained in PharmAcademic and/or in the resident’s folder on the Pharmacy Department shared drive.

Health, dental and vision insurance for resident and dependents, paid time off (PTO), extended sick leave, and professional development days. Use of leave must be arranged in advance with the RPD.

Travel funds (~$2500) are included in the base salary. There is a stipend for scrubs.

Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual

  • Resident Qualifications
  • Early Commitment Policy
  • Pre-employment drug testing
  • Health insurance and Benefits
  • Licensure requirement for 2/3 of the residency year
  • Moonlighting
  • Duty hours/tracking of duty hours
  • Professional, family, and extended leave policies
  • Dismissal policy and consequences of failure to progress

Requirements for successful completion of the residency:

  • California license obtained per residency policy and completion of a minimum of 2/3 of the residency as a licensed CA Pharmacist (deadline for CA pharmacist licensure: October 1)
  • A minimum of 12 months training inclusive of standard vacation, professional and sick leave
  • Completion of all required rotations/learning experiences
  • All required residency goals and objectives evaluated at least once, without any “needs improvement” (At least 80% of G&Os must be “Achieved for the Residency”. Some G&Os may be checked off by the RPD at resident closeout.)
  • Resident closeout completed in PharmAcademic, confirming all tasks are completed
  • Completion of a research project, manuscript and manuscript submission for publication
  • Presentation of research project at a regional, state or national conference
  • Completion of secondary project as assigned, such as MUE, monograph, or QI initiative
  • Completion of all required items on the Investigational Drugs & Research Residency Content (topic discussion) Checklist
  • Completed staffing requirements as outlined by the residency program description
  • Pharmacy Grand Rounds presentation

Pharmacy Residency training programs at UC Davis Health are conducted under the licensed entity within UC Davis Health which is UC Davis Medical Center.